Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The New Cannabis & CBD Therapy for PTSD

This podcast is part of our StockTalk Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public cannabis marketplace. There are around eight million people in the U...
Stockhouse Media | November 6, 2019 |

A Global Construction Play. A Winning Investment Strategy

Meet the construction corporation that’s “committed to building shareholder value by delivering innovative and cost-effective construction solutions.”Minaean SP Construction Corp. (MSP) (TSX-...
Dave Jackson | June 24, 2022 |

PayPal, Northern Data, BIGG Digital Assets: Who creates a 170% return?

We know that the future is digital, especially since the outbreak of Covid-19. While fears about the future prevail in traditional industries, business is going better than ever before for all those who are digital and adaptable. As more and more companies and consumers are re...
Nico Popp | October 9, 2020 |

Buzz on the Bullboards: Doomsday clock ticks seconds to midnight

Trading activity has been picking up on Bay Street and Wall Street lately as investors shake off the winter hibernation doldrums. There hasn’t been any shortage of excitement on the trading floors these days, with Wall Street seeing legitimate bedlam ...
Jonathon Brown | January 26, 2023 |

Pulmatrix's Licensing Deal with the JNJ Lung Cancer Initiative Sends Shares Up 100%

Pulmatrix's shares opened 90% higher today after the firm reported that it has signed a kinase inhibitor licensing agreement with the Lung Cancer Initiative at Johnson & Johnson. Prior to the U.S. markets open this morning on the first day of trading in 2020, clinical...
Streetwise Reports | January 3, 2020 |

BeiGene Shares Up 35% on Amgen's $2.7 Billion Investment and China Partnership

Shares of BeiGene Ltd. traded 35% higher today to a new a 52-week intraday high after announcing a commercialization agreement for of XGEVA (denosumab), KYPROLIS (carfilzomib), and BLINCYTO (blinatumomab) with Amgen Inc. in China. As part of the partnership, Amgen will invest ...
Streetwise Reports | November 4, 2019 |

InMode Reports Solid Q2 Earnings and Appoints Paula Abdul as Brand Ambassador

InMode Ltd. reported Q2/19 earnings and announced that international pop superstar Paula Abdul will be its brand ambassador sending shares "Straight Up" 15% as investors "Rush Rush" to purchase shares today. InMode Ltd. (INMD:NAQDAQ) , a global provider of innovative ...
Streetwise Reports | August 15, 2019 |

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...
Streetwise Reports | September 6, 2019 |

A Company on a Mission to Revolutionize Mental Healthcare. Here’s How.

When Stockhouse Editorial last caught up with Cybin Inc. ( NEO.CYBN , NYSE: CYBIN , Forum ) back in October, our audience learned about a leading biotechnology company focused on researching and progressing psychedelic therapeutics by utilizing proprietary drug discover...
Dave Jackson | January 31, 2022 |

The Cannabis Company that’s Driving “Sustainable Profitability”

(Click image to play video) Getting well and staying well is the goal of everyone. But the ways and means of achieving a state of mental and physical wellbeing alludes millions of us. Luckily, certain forward-thinking, compassionate companies are committed to cre...
Dave Jackson | April 27, 2021 |
1 2 3 4 5 6 7 8 9 10 ...